Location
China, Asia
Cheque size
$10M - $50M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Medical Devices
About Investor
Daisy Xu is a Managing Director (PIM) at Vivo Capital, based in Shanghai. Her investing sits in life sciences and medical equipment, with a typical focus on biotech and medical devices across Seed and Series A, and she’s associated with checks in the $10.0M–$50.0M range. Before joining Vivo, she led commercial operations in Greater China, including roles at Thermo Fisher, Kinetic Concept Inc. (Greater China), and Bio-Rad (Greater China). She holds a B.S. in Pharmaceutics and an M.S. in Bio-engineering from East China University of Science and Technology.
Similar Investors
JF
Jixun Foo
Singapore, Asia
$250K - $25M
Seed
,Series A
,TK
Tuck Lye Koh
Singapore, Asia
$250K - $15M
Pre Seed
,Seed
,JH
Justin Hall
Singapore, Asia
$100K - $10M
Seed
,Series A
,JL
Jenny Lee
Singapore, Asia
$250K - $25M
Seed
,Series A
,CG
Christopher Gomez
Singapore, Asia
$250K - $10M
Pre Seed
,Seed
,JW
Joshua Wu
China, Asia
$250K - $25M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.